Harano Y - Search Results

1

Insulin resistance as an independent risk factor for carotid wall thickening.

Suzuki M, Shinozaki K, Kanazawa A, Hara Y, Hattori Y, Tsushima M, Harano Y. Suzuki M, et al. Among authors: harano y. Hypertension. 1996 Oct;28(4):593-8. doi: 10.1161/01.hyp.28.4.593. Hypertension. 1996. PMID: 8843883

2

Close association of endothelial dysfunction with insulin resistance and carotid wall thickening in hypertension.

Suzuki M, Takamisawa I, Suzuki K, Hiuge A, Horio T, Yoshimasa Y, Harano Y. Suzuki M, et al. Among authors: harano y. Am J Hypertens. 2004 Mar;17(3):228-32. doi: 10.1016/j.amjhyper.2003.11.013. Am J Hypertens. 2004. PMID: 15001196

3

Insulin resistance rather than hyperinsulinemia more closely associated with essential hypertension.

Yokota C, Ikebuchi M, Suzuki M, Norioka M, Ikeda K, Shinozaki K, Harano Y. Yokota C, et al. Among authors: harano y. Clin Exp Hypertens. 1995 Apr;17(3):523-36. doi: 10.3109/10641969509037422. Clin Exp Hypertens. 1995. PMID: 7613526 Free article.

4

Insulin resistance associated with compensatory hyperinsulinemia as an independent risk factor for vasospastic angina.

Shinozaki K, Suzuki M, Ikebuchi M, Takaki H, Hara Y, Tsushima M, Harano Y. Shinozaki K, et al. Among authors: harano y. Circulation. 1995 Oct 1;92(7):1749-57. doi: 10.1161/01.cir.92.7.1749. Circulation. 1995. PMID: 7671357

5

Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke.

Shinozaki K, Naritomi H, Shimizu T, Suzuki M, Ikebuchi M, Sawada T, Harano Y. Shinozaki K, et al. Among authors: harano y. Stroke. 1996 Jan;27(1):37-43. doi: 10.1161/01.str.27.1.37. Stroke. 1996. PMID: 8553400

6

Normalization of insulin resistance in non-obese essential hypertension by cilazapril treatment.

Suzuki M, Ikebuchi M, Yokota C, Shinozaki K, Harano Y. Suzuki M, et al. Among authors: harano y. Clin Exp Hypertens. 1995 Nov;17(8):1257-68. doi: 10.3109/10641969509037407. Clin Exp Hypertens. 1995. PMID: 8563700 Free article.

7

Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects.

Harano Y, Kageyama A, Nakao Y, Hara Y, Suzuki M, Sato A, Ikebuchi M, Shinozaki K, Tsushima M. Harano Y, et al. Diabetes. 1996 Jul;45 Suppl 3:S31-4. doi: 10.2337/diab.45.3.s31. Diabetes. 1996. PMID: 8674886

8

Mechanism and clinical implication of insulin resistance syndrome.

Suzuki M, Ikebuchi M, Shinozaki K, Hara Y, Tsushima M, Matsuyama T, Harano Y. Suzuki M, et al. Among authors: harano y. Diabetes. 1996 Jul;45 Suppl 3:S52-4. doi: 10.2337/diab.45.3.s52. Diabetes. 1996. PMID: 8674891

9

Demonstration of insulin resistance in coronary artery disease documented with angiography.

Shinozaki K, Suzuki M, Ikebuchi M, Hara Y, Harano Y. Shinozaki K, et al. Among authors: harano y. Diabetes Care. 1996 Jan;19(1):1-7. doi: 10.2337/diacare.19.1.1. Diabetes Care. 1996. PMID: 8720524

10

Clinical impact of insulin resistance syndrome in cardiovascular diseases and its therapeutic approach.

Harano Y, Suzuki M, Shinozaki K, Hara Y, Ryomoto K, Kanazawa A, Nishioheda Y, Tsushima M. Harano Y, et al. Hypertens Res. 1996 Jun;19 Suppl 1:S81-5. doi: 10.1291/hypres.19.supplementi_s81. Hypertens Res. 1996. PMID: 9240771 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

194 results

Search Page

Filters